• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Niigata University Medical and Dental Hospital - Developmental Therapeutics Review - Q4 2010 Product Image

Niigata University Medical and Dental Hospital - Developmental Therapeutics Review - Q4 2010

  • Published: December 2010
  • Region: Global
  • 27 pages
  • Global Markets Direct

Niigata University Medical and Dental Hospital – Developmental Therapeutics Review – Q4 2010

Summary

Global Market Direct’s pharmaceuticals report, “Niigata University Medical and Dental Hospital - Developmental Therapeutics Review - Q4 2010” provides data on the company’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Niigata University Medical and Dental Hospital - Brief company overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Niigata University Medical and Dental Hospital human therapeutic division.
- Overview of pipeline therapeutics across various therapy READ MORE >



List of Tables
List of Figures
Niigata University Medical and Dental Hospital Snapshot
Niigata University Medical and Dental Hospital Overview
Key Information
Key Facts
Niigata University Medical and Dental Hospital – Research and Development Overview
Key Therapeutic Areas
Niigata University Medical and Dental Hospital – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Pipeline Products – Combination Treatment Modalities
Niigata University Medical and Dental Hospital – Pipeline Products Glance
Niigata University Medical and Dental Hospital Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Niigata University Medical and Dental Hospital – Drug Profiles
CBDCA + Docetaxel
Product Description
Mechanism of Action
R&D Progress
Imatinib Mesylate for Cancer (Niigata University Medical and Dental Hospital)
Product Description
Mechanism of Action
R&D Progress
Leukine
Product Description
Mechanism of Action
R&D Progress
Paclitaxel + Vinorelbine
Product Description
Mechanism of Action
R&D Progress
Vinorelbine + Zoledronate
Product Description
Mechanism of Action
R&D Progress
Docetaxel + Gefitinib
Product Description
Mechanism of Action
R&D Progress
Niigata University Medical and Dental Hospital – Pipeline Analysis
Niigata University Medical and Dental Hospital – Pipeline Products by Therapeutic Class
Niigata University Medical and Dental Hospital Pipeline Products By Target
Niigata University Medical and Dental Hospital – Pipeline Products by Route of Administration
Niigata University Medical and Dental Hospital – Pipeline Products by Molecule Type
Niigata University Medical and Dental Hospital – Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

Note: Product cover images may vary from those shown

RELATED PRODUCTS